Judge Pauses Louisiana’s Mifepristone Restrictions as FDA Review Looms
A district court judge has stayed Louisiana’s ongoing attempt to restrict access to the abortion medication mifepristone, to allow time for the Food and Drug Administration to finish its own review of the medication—which comes directly at the orders of RFK Jr.



